Statistics for SELLAS Life Sciences Group (id:5861 SLS)


Valuation metrics

Market cap
90.79M
Enterprise value
73.25M
Trailing P/E (ttm)
-0.87
Forward P/E
-3.00
PEG ratio
-3.00
Price/Sales (ttm)
Price/Book (mrq)
5.02
Enterprise Value/Revenue
Enterprise Value/EBITDA
-1.93

Overview

Shares outstanding
64.33M
Float
64.15M
Shares short
8.61M
% Held by insiders
0.00%
% Held by institutions
0.07%
Average volume (10 days)
874.31K
Average volume (90 days)

Price summary

52-Week low
0.50
52-Week high
1.72
52-Week change
10.26%
Beta
2.40
50-Day moving average
1.23
200-Day moving average
1.22

Dividends and splits

Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
November 08th, 2019
Ex-dividend date
Last split factor
2:1
Last split date
November 08th, 2019

Financials

Fiscal year
Fiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-129.15%
Return on equity
-888.06%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
0.00
Net income to common (ttm)
-34,439,000.00
Diluted EPS (ttm)
-0.90
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
9.15M
Total cash per share (mrq)
0.14
Total debt (mrq)
692.00K
Total Debt/Equity (mrq)
23.76
Current ratio (mrq)
102.10%
Book value per share (mrq)
-0.25
Cash flow
Cash flow statement
-32,160,000.00
Levered free cash flow (LFCF)
-26,447,500.00

CleverShares.com|
2024 ©

1.0.9092.25789